Breast Cancer Clinical Trial
Official title:
KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery
The main objective of the study is to investigate the effects of Kinect® video based technology on pain, functionality, muscle strength, fatigue and quality of life in patients with breast cancer surgery and axillary node dissection.
Introduction: Breast cancer is the most common cancer seen in women. 1.7 million new cases
have been reported in the world and have been shown as the fifth cause of death among
women.There are many risk factors in etiogenesis, including gender, family history, age,
obesity, malnutrition in postmenopausal period, hormone therapy, after 30 years of first
birth, alcohol consumption and physical activity inadequacy. Pain and functional disorders
are common complications after post-mastectomy in upper extremity. After mastectomy surgery
,pain in the shoulder, fatigue, decrease in range of motion, restriction of daily living
activities, decrease of muscle strength, postural inbalance,, neuropathy and lymphedema may
occur in the acute and chronic period.
Patients with breast cancer need a multidisciplinary and ongoing physiotherapy program.New
technologies provide more motivational involvement for patients according to regular care and
standard programs. Microsoft Kinect® is a virtual exercise program that is an application. It
has been in use for rehabilitation among physical therapists for different deseas.The Kinect®
application is a special technological approach that allows to follow the movements of the
body. Microsoft Kinect® virtuel reality video games are promissing rehabilitation options
because they involve upper extremity practise.
Subjects and methods: A randomized clinical trial, the examiner being blinded unaware of the
intervention group to which subjects were assigned. Participants will be randomly assigned to
two groups:
Experimental group- where the participants will be treated with standart exercise therapy and
Kinect® video-game-based technology
Control Group - Standart exercise therapy and upper extremity rehabilitation-oriented
physiotherapy program will be applied.
The evaluations will be repeated at the beginning of the study and at the end of the sixth
week. Data obtained from the study will be analyzed using appropriate statistical methods.
Patients will be received to therapy which upper extremity rehabilitation or Kinect based
video game play under physiotherapist supervision for two days a week for six weeks. Patients
will be supported by the home exercise program, except during sessions. Participants' joint
range of motion in the initial assessments will be measured by electro-goniometer, muscle
strength assessment by JTech hand dynamometer at appropriate evaluation positions and grip
force asssessment by Saehan Hydraulic Hand Dynamometer . In assessing pain, pain levels at
rest and during activity will be questioned using Visual Analog Scale. Fear of movement of
individuals will be assessed via Tampa Kinesiophobia Scale and functional levels will be
assessed via Disabilities of the Arm Shoulder and Hand Anketi (DASH). Environmental
measurement differences between upper extremities with and without operation will be assessed
with made in the arm, forearm and the wrist. In assessing Quality of life will be assessed
European Organization for Research and Treatment of Cancer EORTC QLQ-C30 - EORTC- BR23 and
finally fatique of individuals will be assessed via Cancer Fatigue Scale -CFS.
Sample size: 17 women for each group. Data Analysis:Data obtained from the study will be
analyzed using appropriate statistical methods.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |